Citations

Clear

5 citation(s) found for "Chen, Man".

TREM2‐IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke
Yang, Sheng , Qin, Chuan, Chu, Yun‐Hui, Tang, Yue , Zhou, Luo‐Qi , Zhang, Hang , Dong, Ming‐Hao , Pang, Xiao‐Wei, Chen, Lian , Wu, Long‐Jun , Wang, Wei , Wang, Wei , Wu, Long-Jun , Qin, Chuan, Chen, Man , Tian, Dai‐Shi

Mayo Clinic

Advanced Science | December 27, 2023 | Volume: 11 | Issue: 10 | Pages: No page available

10.1002/advs.202305614 | PMID 38151703 Get It

Abstract Microglia, the major resident immune cells in the central nervous system, serve as the frontline soldiers against cerebral ischemic injuries, possibly along with metabolic alterations. However, signaling pathways involved in the regulation of microglial immunometabolism in ischemic stroke remain to be further elucidated. In this study, using single‐nuclei RNA sequencing, a microglial subcluster up‐regulated in ischemic brain tissues is identified, with high expression of Igf1 and Trem2, neuroprotective transcriptional signature and enhanced oxidative phosphorylation. Microglial depletion by PLX3397 exacerbates ischemic brain damage, which is reversed by repopulating the microglia with high Igf1 and Trem2 phenotype. Mechanistically, Igf1 serves as one of the major down‐stream molecules of Trem2, and Trem2‐Igf1 signaling axis regulates microglial functional and metabolic profiles, exerting neuroprotective effects on ischemic stroke. Overexpression of Igf1 and supplementation of cyclocreatine restore microglial glucometabolic levels and cellular functions even in the absence of Trem2. These findings suggest that Trem2‐Igf1 signaling axis reprograms microglial immunometabolic profiles and shifts microglia toward a neuroprotective phenotype, which has promising therapeutic potential in treating ischemic stroke.
Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders
Qin, Chuan, Dong, Ming‐Hao , Yang, Sheng , Zhang, Hang , You, Yun‐Fan , Zhou, Luo‐Qi , Chu, Yun‐Hui, Tang, Yue , Pang, Xiao‐Wei, Wu, Long‐Jun , Wang, Wei , Wu, Long-Jun , Wang, Wei , Qin, Chuan, Chen, Man, Tian, Dai‐Shi

Mayo Clinic

Brain | September 22, 2023 | Volume: 147 | Issue: 1 | Pages: 163-176

10.1093/brain/awad321 | PMID 37740498 Get It

Abstract Microglia-mediated neuroinflammation contributes to acute demyelination in neuromyelitis optica spectrum disorders (NMOSD). Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in the CSF has been associated with microglial activation in several neurodegenerative diseases. However, the basis for this immune-mediated attack and the pathophysiological role of sTREM2 in NMOSD remain to be elucidated. Here, we performed Mendelian randomization analysis and identified a genetic association between increased CSF sTREM2 and NMOSD risk. CSF sTREM2 was elevated in patients with NMOSD and was positively correlated with neural injury and other neuroinflammation markers. Single-cell RNA sequencing of human macrophage/microglia-like cells in CSF, a proxy for microglia, showed that increased CSF sTREM2 was positively associated with microglial dysfunction in patients with NMOSD. Furthermore, we demonstrated that sTREM2 is a reliable biomarker of microglial activation in a mouse model of NMOSD. Using unbiased transcriptomic and lipidomic screens, we identified that excessive activation, overwhelmed phagocytosis of myelin debris, suppressed lipid metabolism and enhanced glycolysis underlie sTREM2-mediated microglial dysfunction, possibly through the nuclear factor kappa B (NF-κB) signalling pathway. These molecular and cellular findings provide a mechanistic explanation for the genetic association between CSF sTREM2 and NMOSD risk and indicate that sTREM2 could be a potential biomarker of NMOSD progression and a therapeutic target for microglia-mediated neuroinflammation.
Staged suppression of microglial autophagy facilitates regeneration in CNS demyelination by enhancing the production of linoleic acid
Zhou, Luo‐Qi , Dong, Ming‐Hao , Hu, Ziwei , Tang, Yue , Chu, Yun‐Hui, Chen, Zhi , Wu, Long‐Jun , Wang, Wei , Qin, Chuan , Hu, Zi-Wei , Chen, Zhi , Wu, Long-Jun , Chen, Man , Yang, Sheng , Tian, Dai‐Shi

Mayo Clinic

Proceedings of the National Academy of Sciences | December 28, 2022 | Volume: 120 | Issue: 1 | Pages: No page available

10.1073/pnas.2209990120 | PMID 36577069 Get It

Microglia play a critical role in the clearance of myelin debris, thereby ensuring functional recovery from neural injury. Here, using mouse model of demyelination following two-point LPC injection, we show that the microglial autophagic–lysosomal pathway becomes overactivated in response to severe demyelination, leading to lipid droplet accumulation and a dysfunctional and pro-inflammatory microglial state, and finally failed myelin debris clearance and spatial learning deficits. Data from genetic approaches and pharmacological modulations, via microglial Atg5 deficient mice and intraventricular BAF A1 administration, respectively, demonstrate that staged suppression of excessive autophagic–lysosomal activation in microglia, but not sustained inhibition, results in better myelin debris degradation and exerts protective effects against demyelination. Combined multi-omics results in vitro further showed that enhanced lipid metabolism, especially the activation of the linoleic acid pathway, underlies this protective effect. Supplementation with conjugated linoleic acid (CLA), both in vivo and in vitro, could mimic these effects, including attenuating inflammation and restoring microglial pro-regenerative properties, finally resulting in better recovery from demyelination injuries and improved spatial learning function, by activating the peroxisome proliferator-activated receptor (PPAR-γ) pathway. Therefore, we propose that pharmacological inhibition targeting microglial autophagic–lysosomal overactivation or supplementation with CLA could represent a potential therapeutic strategy in demyelinated disorders.
Remote Limb Ischemic Postconditioning Protects Against Ischemic Stroke by Promoting Regulatory T Cells Thriving
Yu, Hai‐Han, Ma, Xiao‐Tong , Ma, Xue, Ma, Xue, Chen, Man, Chu, Yun‐Hui, Wu, Long‐Jun , Wang, Wei, Qin, Chuan, Tian, Dai‐Shi , Wu, Long-Jun , Tian, Dai-Shi , Yu, Hai‐Han, Ma, Xiao‐Tong , Ma, Xue, Ma, Xue, Chen, Man, Chu, Yun‐Hui, Wang, Wei, Qin, Chuan

Mayo Clinic

Journal of the American Heart Association | November 2, 2021 | Volume: 10 | Issue: 22 | Pages: No page available

10.1161/jaha.121.023077 | PMID 34726065 Get It

Background Remote limb ischemic postconditioning (RLIPoC) has been demonstrated to protect against ischemic stroke. However, the underlying mechanisms of RLIPoC mediating cross‐organ protection remain to be fully elucidated. Methods and Results Ischemic stroke was induced by middle cerebral artery occlusion for 60 minutes. RLIPoC was performed with 3 cycles of 10‐minute ischemia followed by 10‐minute reperfusion of the bilateral femoral arteries immediately after middle cerebral artery reperfusion. The percentage of regulatory T cells (Tregs) in the spleen, blood, and brain was detected using flow cytometry, and the number of Tregs in the ischemic hemisphere was counted using transgenic mice with an enhanced green fluorescent protein‐tagged Foxp3. Furthermore, the metabolic status was monitored dynamically using a multispectral optical imaging system. The Tregs were conditionally depleted in the depletion of Treg transgenic mice after the injection of the diphtheria toxin. The inflammatory response and neuronal apoptosis were investigated using immunofluorescent staining. Infarct volume and neurological deficits were evaluated using magnetic resonance imaging and the modified neurological severity score, respectively. The results showed that RLIPoC substantially reduced infarct volume, improved neurological function, and significantly increased Tregs in the spleen, blood, and ischemic hemisphere after middle cerebral artery occlusion. RLIPoC was followed by subsequent alteration in metabolites, such as flavin adenine dinucleotide and nicotinamide adenine dinucleotide hydrate, both in RLIPoC‐conducted local tissues and circulating blood. Furthermore, nicotinamide adenine dinucleotide hydrate can mimic RLIPoC in increasing Tregs. Conversely, the depletion of Tregs using depletion of Treg mice compromised the neuroprotective effects conferred by RLIPoC. Conclusions RLIPoC protects against ischemic brain injury, at least in part by activating and maintaining the Tregs through the nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide hydrate pathway.
Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders
Tao, Ran , Qin, Chuan , Yu, Hai-Han, Wu, Long‐Jun , Bu, Bitao , Tian, Dai‐Shi , Wu, Long-Jun , Tian, Dai-Shi , Chen, Man

Mayo Clinic

International Journal of Neuroscience | January 23, 2020 | Volume: 130 | Issue: 11 | Pages: 1161-1165

10.1080/00207454.2020.1720676 | PMID 31971044 Get It